# Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis

> **NCT03388866** · PHASE4 · COMPLETED · sponsor: **Casa Espirita Terra de Ismael** · enrollment: 91 (actual)

## Conditions studied

- Atopic Dermatitis
- Effects of Immunotherapy

## Interventions

- **DRUG:** Mite extract sublingual immunotherapy (SLIT)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03388866
- **Lead sponsor:** Casa Espirita Terra de Ismael
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-02
- **Primary completion:** 2019-10-30
- **Final completion:** 2020-06-26
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2020-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388866, "Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03388866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*